Click here for Products
Stanford-StartX Fund Backed Nirmidas Bioteh, Raises $2 Million for Diagnostic Research Tools
08-18-2014

PRWEB

"With pGOLD technology, afflictions such as cancer, auto-immune disorders, cardiovascular disease, and diabetes can be detected at earlier stages and with better accuracy by creating non-invasive, point-of-care testing. Early detection could significantly change the nature and cost of patient care."


Contact us

For General Inquiries Email: info@nirmidas.com

For Product Support Email: support@nirmidas.com

Address

Nirmidas Biotech, Inc.

319 N. Bernardo Ave

Mountain View, CA, 94043, USA